BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10090607)

  • 1. Leukoencephalopathy complicating an Ommaya reservoir and chemotherapy.
    Stone JA; Castillo M; Mukherji SK
    Neuroradiology; 1999 Feb; 41(2):134-6. PubMed ID: 10090607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encephaloclastic cyst: a rare complication of a malfunctioning methotrexate Ommaya reservoir.
    Lubomski M; Pell M; Lochhead A; Jude M
    Intern Med J; 2018 Feb; 48(2):224-226. PubMed ID: 29415363
    [No Abstract]   [Full Text] [Related]  

  • 3. Methotrexate-induced leukoencephalopathy. A case report.
    Ilhan I; Cila A; Büyükpamukçu M; Akyüz C; Kutluk T; Berberoğlu S
    Turk J Pediatr; 1995; 37(3):275-8. PubMed ID: 7502368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraventricular chemotherapy.
    Obwegeser A; Seiwald M; Stockhammer G
    J Neurosurg; 1998 Jul; 89(1):172-3. PubMed ID: 9647198
    [No Abstract]   [Full Text] [Related]  

  • 5. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
    Chamberlain MC; Kormanik PA; Barba D
    J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
    Küker W; Bader P; Herrlinger U; Heckl S; Nägele T
    J Neurooncol; 2005 May; 73(1):47-9. PubMed ID: 15933817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
    Counsel P; Khangure M
    Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.
    Ziereisen F; Dan B; Azzi N; Ferster A; Damry N; Christophe C
    Pediatr Radiol; 2006 Mar; 36(3):205-12. PubMed ID: 16369780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT and MRI appearances of methotrexate leucoencephalopathy.
    Wilks MJ; Tie ML; Pozza CH
    Australas Radiol; 2002 Mar; 46(1):80-3. PubMed ID: 11966594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate-induced toxic leukoencephalopathy.
    Gowan GM; Herrington JD; Simonetta AB
    Pharmacotherapy; 2002 Sep; 22(9):1183-7. PubMed ID: 12222556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebral hematoma as a complication of intrathecal methotrexate administration.
    Boran P; Tokuc G; Boran BO; Oktem S
    Pediatr Blood Cancer; 2008 Jan; 50(1):152-4. PubMed ID: 16615061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrotizing encephalopathy following intraventricular instillation of methotrexate.
    Shapiro WR; Chernik NL; Posner JB
    Arch Neurol; 1973 Feb; 28(2):96-102. PubMed ID: 4739170
    [No Abstract]   [Full Text] [Related]  

  • 13. Methotrexate induced brain necrosis and severe leukoencephalopathy due to disconnection of an Ommaya device.
    de Waal R; Algra PR; Heimans JJ; Wolbers JG; Scheltens P
    J Neurooncol; 1993 Mar; 15(3):269-73. PubMed ID: 8360713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome mimicking acute methotrexate-associated encephalopathy in an adolescent patient with lymphoblastic lymphoma.
    Terui K; Takahashi Y; Sasaki S; Kudo K; Kamio T; Ito E
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):615-6. PubMed ID: 20463610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy.
    Hamamoto K; Oriuchi N; Kanazawa T; Higuchi T; Endo K
    Pediatr Neurol; 2009 Apr; 40(4):306-9. PubMed ID: 19302946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient encephalopathy following high-dose methotrexate.
    Lee AC; Li CH; Wong YC
    Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
    [No Abstract]   [Full Text] [Related]  

  • 17. Computer-aided detection of therapy-induced leukoencephalopathy in pediatric acute lymphoblastic leukemia patients treated with intravenous high-dose methotrexate.
    Glass JO; Reddick WE; Li CS; Laningham FH; Helton KJ; Pui CH
    Magn Reson Imaging; 2006 Jul; 24(6):785-91. PubMed ID: 16824973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of reversible cerebral neurotoxicity and irreversible cerebellar atrophy following an intrathecal methotrexate chemotherapy: two case reports.
    Masterson K; Merlini L; Lövblad KO
    J Neuroradiol; 2009 May; 36(2):112-4. PubMed ID: 18722663
    [No Abstract]   [Full Text] [Related]  

  • 19. Ogilvie's syndrome during chemotherapy with high-dose methotrexate for primary CNS lymphoma.
    Xie H; Peereboom DM
    J Clin Oncol; 2012 Jul; 30(21):e192-4. PubMed ID: 22711852
    [No Abstract]   [Full Text] [Related]  

  • 20. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings.
    Dicuonzo F; Salvati A; Palma M; Lefons V; Lasalandra G; De Leonardis F; Santoro N
    J Child Neurol; 2009 Aug; 24(8):1013-8. PubMed ID: 19307676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.